title: Topoisomerases in human leukemia.
authors.affiliation: Oncology Center, Johns Hopkins Hospital, Baltimore, Maryland 21287, USA.
authors.forename: D
authors.initials: D
authors.lastname: Peereboom
authors.forename: M
authors.initials: M
authors.lastname: Charron
authors.forename: S H
authors.initials: SH
authors.lastname: Kaufmann
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002166:Camptothecin / Q000627:therapeutic use; D004264:DNA Topoisomerases, Type I / Q000502:physiology; D004250:DNA Topoisomerases, Type II / Q000502:physiology; D019008:Drug Resistance, Neoplasm; D006413:Hematopoietic System / Q000503:physiopathology; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000201:enzymology; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors
chemical_list: D000970:Antineoplastic Agents; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors; D004264:DNA Topoisomerases, Type I; D004250:DNA Topoisomerases, Type II; D002166:Camptothecin